NR-662_多克隆抗流感病毒H9血凝素(HA),A/HongKong/1073/1999(H9N2),(antiserum,Sheep)(多克隆抗血清)
产品图片
货号/SKU
NR-662
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-662?? Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Hong Kong/1073/1999 (H9N2), (antiserum, Sheep)(Polyclonal Antiserum)|Influenza A virus|Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Hong Kong/1073/1999 (H9N2), (antiserum, Sheep)|-20°C to -40°C|NIH - Influenza Pandemic Preparedness in Asia ProgramAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Hong Kong/1073/1999 (H9N2), (antiserum, Sheep), NR-662."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Antiserum to the H9 hemagglutinin (HA) from influenza virus A/Hong Kong/1073/1999 (H9N2) was produced by immunization of sheep with the recombinant protein.
NR-662 did not pass sterility testing and is not appropriate for tissue culture or in vivo assays.
NR-662 is specific to the H9 HA subtype of influenza virus as determined in serological hemagglutination inhibition (HI) assays. Within the H9 HA subtype, NR-662 is specific to Eurasian strains, except for those of Korea-like lineage, based on HI and ELISA assays. NR-662 demonstrates low reactivity with recent North American H9 HA isolates.
Each vial contains lyophilized (0.5 mL) sheep polyclonal antiserum to the H9 HA from influenza virus A/Hong Kong/1073/1999 (H9N2).
NR-662 should be reconstituted with 0.5 mL of sterile distilled water. Note: Reconstitution with PBS (per the vial label) will result in excess salt.
Antiserum to the H9 hemagglutinin (HA) from influenza virus A/Hong Kong/1073/1999 (H9N2) was produced by immunization of sheep with the recombinant protein.
NR-662 did not pass sterility testing and is not appropriate for tissue culture or in vivo assays.
NR-662 is specific to the H9 HA subtype of influenza virus as determined in serological hemagglutination inhibition (HI) assays. Within the H9 HA subtype, NR-662 is specific to Eurasian strains, except for those of Korea-like lineage, based on HI and ELISA assays. NR-662 demonstrates low reactivity with recent North American H9 HA isolates.
Each vial contains lyophilized (0.5 mL) sheep polyclonal antiserum to the H9 HA from influenza virus A/Hong Kong/1073/1999 (H9N2).
NR-662 should be reconstituted with 0.5 mL of sterile distilled water. Note: Reconstitution with PBS (per the vial label) will result in excess salt.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到北欧批准. 来自流感病毒的H9 Hemagglutinin(HA)的抗血清A /香港/ 1073/1999(H9N2)是通过免疫制作的用重组蛋白的绵羊. NR-662没有通过无菌测试,并且不适用于组织培养或体内组织培养或分析. NR-662特异于流感病毒的H9 HA亚型,如血清学血凝抑制(HI)测定中确定的.在H9 HA亚型中,NR-662特定于欧亚菌株,除了韩国的血统,基于HI和ELISA测定. NR-662与近期北美H9公顷分离株展示了低反应性. 每个小瓶含有来自流感病毒A /香港/ 1073/1999(H9N2)的H9公顷的冻干(0.5毫升)绵羊多克隆抗血清. NR-662应使用0.5毫升无菌蒸馏水重构.注意:使用PBS重建(按小瓶标签)将导致多余的盐.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2022-04-01
2022-08-11
2021-12-21
2021-12-13
2022-06-17
2022-01-10
2022-06-17
2022-04-01
2022-04-01
2024-01-21
2022-03-31